Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.02 USD | -2.52% | +8.42% | -61.01% |
May. 01 | Moleculin Biotech, Inc. Announces Formation of Annamycin Scientific Advisory Board and Inaugural Appointment of Martin Tallman | CI |
Apr. 25 | Transcript : Moleculin Biotech, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-61.01% | 11.18M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- MBRX Stock
- News Moleculin Biotech, Inc.
- HC Wainwright Initiates Moleculin Biotech With Buy Rating, Price Target is $3